Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 2
This trial was for people with who had a high risk of their leukaemia coming back.
It was supported by Cancer Research UK. People could join between 2012 and 2015. The team published the results in 2020.
Recruitment start: 6 February 2012
Recruitment end: 8 October 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Pettitt
Baxter Ltd
Cancer Research UK
Cancer Research UK Liverpool Cancer Trials Unit (LCTU)
Celgene Ltd
Chugai Pharmaceutical Co Ltd
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Royal Liverpool and Broadgreen University Hospital NHS Trust
University of Liverpool
Last reviewed: 30 Jan 2026
CRUK internal database number: 3492